Cooper Companies reported $552.1M in Gross Profit on Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbott ABT:US $ 5.78B 543M
Abiomed ABMD:US $ 217.04M 7.48M
Align Technology ALGN:US $ 619.17M 68.39M
Atricure ATRC:US $ 61.71M 1.81M
Atrion ATRI:US 20.83M 3.46M
Baxter International BAX:US $ 1.15B 310M
Bayer BAYN:GR 7.03B 105M
Becton, Dickinson and BDX:US $ 2.08B 9M
Boston Scientific BSX:US $ 2.18B 42M
Cooper Companies COO:US $ 552.1M 19.6M
Dexcom DXCM:US $ 494.2M 44.7M
Edwards Lifesciences EW:US $ 1.07B 37.7M
Hologic HOLX:US $ 522.9M 36.1M
Insulet PODD:US $ 188.3M 2M
Integra Lifesciences IART:US $ 240.94M 13.6M
Intuitive Surgical ISRG:US $ 1.05B 28.8M
Johnson & Johnson JNJ:US $ 15.98B 134M
Medtronic MDT:US $ 4.87B 650M
Merit Medical Systems MMSI:US $ 128.57M 6.49M
Novartis NVS:US $ 9.18B 151M
Nuvasive NUVA:US $ 214.41M 10.28M
Resmed RMD:US $ 540.81M 18.3M
Steris STE:US $ 532.33M 14.54M
Stryker SYK:US $ 2.8B 41M
Tandem Diabetes Care TNDM:US $ 104.42M 2.48M
Teleflex TFX:US $ 373.96M 14.88M
Valeant Pharmaceuticals VRX:CN $ 2.02B 232.15M
Zimmer Biomet Holdings Inc ZBH:US $ 1.18B 89.2M